Flagship VentureLabs IV, LLC → Seres Therapeutics, Inc. MCRB

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 12.06

597,314 shares short · -5.0% vs prior

Other 13D/G Filings on Seres Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2024-10-02	SC	NESTLE SA	—	—	view →
2022-07-07	SC	Flagship VentureLabs IV, LLC	—	—	view →
2020-08-19	SC	Nestle Health Science US Holdings, Inc.	—	—	view →

Other Filings by Flagship VentureLabs IV, LLC

Filed	Form	Issuer	Stake	Shares
2022-09-23	SC	Axcella Health Inc.	—	—	view →
2022-07-07	SC	Seres Therapeutics, Inc. MCRB	—	—	view →
2022-03-18	SC	Axcella Health Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →